Peptic Ulcer Disease
📧 Sign up to get email alerts when something new happens for Peptic Ulcer Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-05-15FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for Prilosec (omeprazole magnesium) filed by Covis Pharma US, Inc.
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Supplementary Angiographic Embolization for Peptic Ulcer Bleeding [NA]
Clinical trial update on supplementary angiographic embolization for peptic ulcer disease with hemorrhage; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Residual Gastric Volume After the Ingestion of a Beverage Containing Carbohydrates Plus Whey Protein [Phase 2, Phase 3]
Completed Phase 2/3 clinical trial from Federal University of Mato Grosso evaluating residual gastric volume after ingestion of a carbohydra…
-
FDA approval · 2013-04-01FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for Pepcid AC Maximum Strength (famotidine) by Kenvue Brands LLC.
-
FDA approval · 2013-03-04FDA Approved: SUCRALFATE — Supplemental Application (Mylan Pharmaceuticals, Inc.)
FDA approved a supplemental application for SUCRALFATE submitted by Mylan Pharmaceuticals, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-03-04FDA Approved: CARAFATE — Supplemental Application (Allergan, Inc.)
The FDA approved Allergan's supplemental application for Carafate (sucralfate). This action updates the labeling and approved uses based on …
-
FDA approval · 2013-02-22FDA Approved: FAMOTIDINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for famotidine submitted by Alembic Pharmaceuticals Inc.
-
FDA approval · 2013-02-11FDA Approved: NIZATIDINE — Supplemental Application (Epic Pharma, LLC)
FDA approved Epic Pharma, LLC's supplemental application to market a generic nizatidine product (an H2 receptor blocker) under an ANDA, expa…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage [Phase 2]
A Phase 2 clinical trial evaluating pantoprazole for peptic ulcer hemorrhage has completed, with Wyeth now a part of Pfizer.
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer [Phase 2]
A Phase 2 trial tested whether a proton pump inhibitor can prevent clopidogrel-related peptic ulcers. The study is completed and results wer…
-
FDA approval · 2013-01-23FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the fixed-dose combination of bismuth subcitrate potassium, metronidazole, and tetracycline hydr…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment [Phase 4]
A Phase 4 clinical trial update reports that adding bismuth to a levofloxacin-containing triple therapy may improve Helicobacter pylori trea…
-
FDA approval · 2012-11-13FDA Approved: CIMETIDINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for cimetidine, resulting in an expanded label/approval for the drug.
-
FDA approval · 2012-11-13FDA Approved: CIMETIDINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for cimetidine, updating the product under an existing approval.
-
FDA approval · 2012-10-09FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2012-10-09FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Protonix Delayed-Release (pantoprazole sodium) from Wyeth/Pfizer to modify/expand its labeling.
-
FDA approval · 2012-09-28FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Nexium (esomeprazole magnesium) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2012-09-28FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Prevacid Solutab (lansoprazole) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2012-09-28FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application to add an intravenous formulation of pantoprazole (PROTONIX I.V.) from Wyeth Pharmaceuticals (Pf…
-
CLINICAL_TRIALS trial_result · 2012-09-18Clinical Trial Update: Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal Bleeding [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of somatostatin for acute severe upper gastrointestinal bleeding due to peptic ulcer has …
-
FDA approval · 2012-09-07FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Pantoprazole sodium from Mylan Pharmaceuticals Inc., continuing approval for this generic produc…
-
CLINICAL_TRIALS trial_result · 2012-08-17Clinical Trial Update: Aizthromycin or Clarithromycin in H-pylori Eradication Regimen [Phase 4]
A Phase 4 trial comparing azithromycin (Aizthromycin) and clarithromycin for Helicobacter pylori eradication in peptic ulcer disease and dys…
-
CLINICAL_TRIALS other · 2012-06-21Clinical Trial Update: Oral Versus IV Proton Pump Inhibitor in High-risk Bleeding Peptic Ulcers After Endoscopic Hemostasis [Phase 3]
A Phase 3 clinical trial evaluating whether oral pantoprazole is as effective as intravenous pantoprazole for preventing rebleeding in patie…
-
FDA approval · 2012-06-13FDA Approved: FAMOTIDINE — Supplemental Application (Carlsbad Technology, Inc)
FDA approved a supplemental application for famotidine from Carlsbad Technology, Inc.
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708) [Phase 3]
Phase 3 long-term trial of pantoprazole in patients with chronic acid-related symptoms (GERD and peptic ulcers) has completed.